Research Peptides

N-PEP-12

N-PEP-12 (marketed commercially as Memoprove) is a proprietary preparation of neuropeptides derived from a standardized enzymatic process. This peptide mixture has been studied in clinical trials for its effects on memory, cognitive function, and attention in elderly subjects with age-associated memory impairment (AAMI). Research suggests N-PEP-12 may modulate cholinergic and glutamatergic neurotransmission, promote synaptic plasticity, and provide neuroprotective effects. While the exact composition and mechanism of action are not fully disclosed due to proprietary protections, N-PEP-12 has shown promising results in several controlled clinical studies for cognitive enhancement.

Technical Specifications

Sequence / StructureProprietary neuropeptide mixture
Molecular WeightMixture (multiple peptides <10 kDa)
PurityStandardized preparation (≥95% peptide content)
AppearanceClear to slightly opalescent liquid or lyophilized powder
StorageStore at 2-8°C, protect from light
SolubilityProvided in aqueous solution or reconstituted in water

Application Areas

  • Cognitive function research
  • Memory enhancement studies
  • Neuroprotection research
  • Synaptic plasticity studies
  • Aging cognition research

Published Research on N-PEP-12

Moessler H, Bhatt A. (2005) — A randomized, double-blind, placebo-controlled study of N-PEP-12 on memory, attention, and cognitive improvement in elderly subjects. J Alzheimers Dis. DOI: 10.3233/JAD-2005-8406

Windisch M. (2000) — Approach towards an integrative drug treatment of Alzheimer's disease. J Neural Transm. DOI: 10.1007/978-3-7091-6301-6_12

Frequently Asked Questions About N-PEP-12

N-PEP-12 is a standardized neuropeptide preparation studied for its effects on memory, attention, and cognitive function in age-related cognitive decline.

N-PEP-12 is provided as a standardized preparation with ≥95% peptide content.

Applications include cognitive function, memory enhancement, neuroprotection, and age-related cognitive decline research.

Store at 2-8°C protected from light. Follow specific batch documentation for handling.

Contact our sales team for MOQ and pricing details.

While both are neuropeptide preparations, N-PEP-12 is orally available and targets age-related memory decline, whereas Cerebrolysin requires parenteral administration and is studied for more severe neurological conditions.

Related Research Peptides

Request Price List